
Egyptian Association of Vascular Biology and Atherosclerosis (EAVA) consensus on the usage of pro protein convertase subtilisin/kexin type 9 (PCSK9) inhibitors
Reda, Ashraf, Elserafy, Ahmed Shawky, Farag, Elsayed, Mostafa, Tamer, Farag, Nabil, Elbahry, Atef, Sanad, Osama, Bendary, Ahmed, Elkersh, Ahmed, Attia, Ihab, Beshay, Morad, Selim, Mohammed, Khamis, HaVolume:
41
Journal:
Atherosclerosis Supplements
DOI:
10.1016/j.atherosclerosissup.2020.01.002
Date:
April, 2020
Fichier:
PDF, 117 KB
2020